Li Mo
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Liver physiology and pathology
Papers in
-
- Liver physiology and pathology 5
-
- Nanoparticle-Based Drug Delivery 5
- Co-authors
- David Hui (5 shared papers)Carlos Eduardo Paiva (1 shared paper)Yanping Li (7 shared papers)Jinhan He (9 shared papers)Qinhui Liu (6 shared papers)Qin Tang (6 shared papers)Anna Collins (3 shared papers)Jinhang Zhang (6 shared papers)
- Journals
- Molecular Pharmaceutics (2 papers)Advanced Science (2 papers)Circulation Heart Failure (1 paper)Journal of Controlled Release (1 paper)The Oncologist (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Li Mo
15 papers receiving 461 citations
Peers
Comparison fields: 5 of 74
- Biomaterials 78
- Hepatology 44
- Public Health, Environmental and Occupational Health 157
- Nephrology 42
- Drug Discovery 1
Countries citing papers authored by Li Mo
This map shows the geographic impact of Li Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Mo more than expected).
Fields of papers citing papers by Li Mo
This network shows the impact of papers produced by Li Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Mo. The network helps show where Li Mo may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Mo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 62 | |
| 2 | 2020 | 60 | |
| 3 | 2020 | 55 | |
| 4 | 2021 | 53 | |
| 5 | 2019 | 40 | |
| 6 | 2023 | 36 | |
| 7 | 2020 | 31 | |
| 8 | 2020 | 30 | |
| 9 | 2021 | 24 | |
| 10 | 2024 | 20 | |
| 11 | 2021 | 19 | |
| 12 | 2021 | 18 | |
| 13 | 2023 | 18 | |
| 14 | 2022 | 6 | |
| 15 | 2025 | 2 | |
| 16 | 2026 | 0 |
About Li Mo
Li Mo is a scholar working on Hepatology, Biomaterials, Public Health, Environmental and Occupational Health, Endocrine and Autonomic Systems and Pharmacology, having authored 16 papers that have together received 474 indexed citations. Recurring topics across this work include Liver physiology and pathology (5 papers), Nanoparticle-Based Drug Delivery (5 papers), Palliative Care and End-of-Life Issues (5 papers), RNA Interference and Gene Delivery (1 paper), Palliative and Oncologic Care (1 paper), Endoplasmic Reticulum Stress and Disease (1 paper), Adipose Tissue and Metabolism (1 paper) and Chronic Kidney Disease and Diabetes (1 paper). The work is most often cited by research in Biomaterials (78 citations), Hepatology (44 citations), Public Health, Environmental and Occupational Health (157 citations), Nephrology (42 citations) and Drug Discovery (1 citation). Li Mo has collaborated with scholars based in China, United States and Australia. Frequent co-authors include David Hui, Carlos Eduardo Paiva, Yanping Li, Jinhan He, Qinhui Liu, Qin Tang, Anna Collins, Jinhang Zhang, Jennifer A. M. Philip and Yimin Geng. Their work appears in journals such as Molecular Pharmaceutics, Advanced Science, Circulation Heart Failure, Journal of Controlled Release and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.